Shearman Logo

News Jun 08, 2015

Shearman & Sterling Advises Underwriters in Connection with Secondary Offering of Catalent, Inc.

Shearman & Sterling represented Morgan Stanley, J.P. Morgan, BofA Merrill Lynch, Goldman, Sachs & Co., Jefferies, Deutsche Bank Securities, Blackstone Capital Markets, Evercore ISI, Raymond James, Wells Fargo Securities and William Blair as underwriters in connection with a secondary public offering of 16,100,000 shares of common stock of Catalent, Inc. by certain of its stockholders, including 2,100,000 shares sold pursuant to the over-allotment option granted to the underwriters by the Selling Stockholders in connection with the offering, which was exercised in full. Catalent, Inc. is the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products.

The Shearman & Sterling team advising the underwriters included partners Merritt Johnson (New York-Capital Markets), and Russell Sacks (New York-Financial Institutions Advisory & Financial Regulatory) and associates Jennifer Morton (New York-Financial Institutions Advisory & Financial Regulatory), Michael Daly (Washington, DC-Tax), Jon Shields (New York-Capital Markets), Jenny Ding (New York-Corporate) and Hillary Bailey (New York-Corporate).